Smaller Prostate Size Predicts High Grade Prostate Cancer at Final Pathology
Authors:
- 1 September 2010
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 184 (3) , 930-937
Abstract
Prostate size may influence the likelihood of detecting high grade prostate cancer at final pathology. We evaluated the association between prostate size and high grade (Gleason score 7 or greater) cancer. We analyzed data from 2,880 patients who underwent surgical treatment of prostate cancer between January 2000 and June 2008. Prostate size measured at prostatectomy was compared across a strata of clinical variables (age, body mass index, prostate specific antigen, biopsy Gleason score, clinical stage and year of surgery) and pathological outcomes (final Gleason score, extraprostatic extension, positive surgical margin, seminal vesicle invasion and lymph node involvement). Multivariate logistic regression was used to assess prostate size as a predictor of high grade cancer. Older age, higher prostate specific antigen and later year of surgery were associated with larger gland size. Small prostate size was associated with high grade prostate cancer as well as extraprostatic extension and positive surgical margins on univariate and adjusted analysis. The probability of high grade disease decreased approximately 15% across the lowest vs highest prostate sizes. On multivariate analysis adjusted for age, race, prostate specific antigen, clinical stage, biopsy Gleason score and date of surgery prostate size was an important predictor of high grade disease (OR 0.94; 95% CI 0.92, 0.97 per 2 gm increments, p <0.001). The area under the ROC curve was 0.82 (95% CI 0.81, 0.84). Prostate size was inversely associated with the risk of high grade cancer at final pathology. The ability to predict high grade disease could have implications for the management of prostate cancer.Keywords
This publication has 29 references indexed in Scilit:
- Recommendations for the Reporting of Prostate CarcinomaAmerican Journal of Clinical Pathology, 2008
- Prostate volume and adverse prostate cancer features: Fact not artifactEuropean Journal of Cancer, 2007
- Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention TrialJNCI: Journal of the National Cancer Institute, 2007
- Effect of Prostate Volume on Tumor Grade in Patients Undergoing Radical Prostatectomy in the Era of Extended Prostatic BiopsiesJournal of Urology, 2007
- Evidence for a Biopsy Derived Grade Artifact Among Larger Prostate GlandsJournal of Urology, 2006
- Hepatic Resection: The Last Surgical Frontier for Colorectal CancerJournal of Clinical Oncology, 2005
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Multiple Imputation in PracticeThe American Statistician, 2001
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinomaCancer, 1997